Platinum-sensitive Recurrent Ovarian Cancer

• CLINICAL_TRIALS trial_result · 2025-03-20
  Clinical Trial Update: QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer [Phase 4]

  Phase 4 trial comparing trabectedin plus pegylated liposomal doxorubicin versus platinum-based therapy in platinum-sensitive recurrent ovari…

• CLINICAL_TRIALS trial_result · 2021-07-12
  Clinical Trial Update: Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor [Phase 2]

  Phase 2 trial update evaluating niraparib and bevacizumab as maintenance therapy in platinum-sensitive recurrent ovarian cancer patients pre…